Skip to main content
. Author manuscript; available in PMC: 2020 Jan 3.
Published in final edited form as: Biochemistry. 2019 Aug 26;58(36):3813–3822. doi: 10.1021/acs.biochem.9b00523

Figure 2.

Figure 2.

Mechanism by which BPEI makes MRSA susceptible via WTA. BPEI and oxacillin have synergy against MRSA MW2. Synergy is lost against (A) MRSA MW2 ΔtarO and (B) MRSA MW2 with sublethal tunicamycin (0.250 μg/mL). Each assay was performed as three separate trials, and the presented data are shown as the average change in OD600.